$ 25 million investment to VC fund, Integra Holdings, who is bringing the Hebrew U’s Life Science Academic Excellence to market, led by Temasek (SIngapore)

September 27th, 2017 – Integra Holdings, an investment company exclusively focused on life science innovations originating from the Hebrew University, today announced the first closing of a $25 million investment. Temasek, which led the round with an investment of $15M, was joined by Arie Capital, with an initial investment of $2M. The Israeli Teachers’ and Kindergartens’ Study Funds, one of Integra’s current shareholders, also participated in this financing round.

The funds raised will be used to advance Integra Holdings’ existing portfolio companies and to create new companies, based on promising technologies originating from the Hebrew University of Jerusalem.

“I am proud to welcome Temasek and Arie Capital to our circle of investors” said Dr. Liana Patt, CEO Integra Holdings. “This strategic investment reinforces the global recognition of the Hebrew University’s exceptional contribution to life science innovations and Integra’s robust and growing portfolio”.

Temasek is an investment company, headquartered in Singapore, with a net portfolio value of US$197 billion (as of 31 March 2017). Temasek operates through 10 international offices and a staff of over 630 people globally.

“This latest round of investment will allow more breakthrough discoveries to realize their potential and reach a broader community of entrepreneurs, investors and industry partners” said Mr. Lior Buchman, CFO Integra Holdings.

For more information, see: http://www.integra-holdings.com/news/temasek-leads-25-million-investment-round-in-integra-holdings/#

Show Buttons
Share On Facebook
Share On Twitter
Share On Google Plus
Share On Linkedin
Hide Buttons